Radin D, Lippa A, Rana S, Fuller D, Smith J, Cerne R
Pharmacol Biochem Behav. 2025; 248:173967.
PMID: 39894310
PMC: 11849398.
DOI: 10.1016/j.pbb.2025.173967.
Southon C
Front Psychol. 2022; 13:958013.
PMID: 36118426
PMC: 9478894.
DOI: 10.3389/fpsyg.2022.958013.
Rychik N, Fassett-Carman A, Snyder H
J Atten Disord. 2020; 25(12):1676-1686.
PMID: 32495709
PMC: 7735255.
DOI: 10.1177/1087054720925900.
Lopez P, Torrente F, Ciapponi A, Lischinsky A, Cetkovich-Bakmas M, Rojas J
Cochrane Database Syst Rev. 2018; 3:CD010840.
PMID: 29566425
PMC: 6494390.
DOI: 10.1002/14651858.CD010840.pub2.
Chu R, Rosic T, Samaan Z
Case Rep Psychiatry. 2017; 2017:1364894.
PMID: 28695034
PMC: 5485267.
DOI: 10.1155/2017/1364894.
How Humans Solve Complex Problems: The Case of the Knapsack Problem.
Murawski C, Bossaerts P
Sci Rep. 2016; 6:34851.
PMID: 27713516
PMC: 5054396.
DOI: 10.1038/srep34851.
Attention-deficit/hyperactivity disorder and adverse health outcomes.
Nigg J
Clin Psychol Rev. 2013; 33(2):215-28.
PMID: 23298633
PMC: 4322430.
DOI: 10.1016/j.cpr.2012.11.005.
Maternal ADHD, Parenting, and Psychopathology Among Mothers of Adolescents With ADHD.
Babinski D, Pelham Jr W, Molina B, Gnagy E, Waschbusch D, Wymbs B
J Atten Disord. 2012; 20(5):458-68.
PMID: 23160485
PMC: 3582708.
DOI: 10.1177/1087054712461688.
Women with Childhood ADHD: Comparisons by Diagnostic Group and Gender.
Babinski D, Pelham Jr W, Molina B, Waschbusch D, Gnagy E, Yu J
J Psychopathol Behav Assess. 2012; 33(4):420-429.
PMID: 22228922
PMC: 3251258.
DOI: 10.1007/s10862-011-9247-4.
An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety.
Dopfner M, Gortz-Dorten A, Breuer D, Rothenberger A
Eur Child Adolesc Psychiatry. 2011; 20 Suppl 2:S243-55.
PMID: 21901417
PMC: 3180616.
DOI: 10.1007/s00787-011-0202-4.
Adult attention deficit hyperactivity disorder is associated with asthma.
Fasmer O, Halmoy A, Eagan T, Oedegaard K, Haavik J
BMC Psychiatry. 2011; 11:128.
PMID: 21819624
PMC: 3163523.
DOI: 10.1186/1471-244X-11-128.
Adult attention deficit hyperactivity disorder is associated with migraine headaches.
Fasmer O, Halmoy A, Oedegaard K, Haavik J
Eur Arch Psychiatry Clin Neurosci. 2011; 261(8):595-602.
PMID: 21394551
PMC: 3225610.
DOI: 10.1007/s00406-011-0203-9.
Test of variables of attention (TOVA) as a predictor of early attention complaints, an antecedent to dementia.
Braverman E, Chen A, Chen T, Schoolfield J, Notaro A, Braverman D
Neuropsychiatr Dis Treat. 2010; 6:681-90.
PMID: 21127685
PMC: 2987500.
DOI: 10.2147/NDT.S12243.
Long-term consequences of childhood ADHD on criminal activities.
Fletcher J, Wolfe B
J Ment Health Policy Econ. 2009; 12(3):119-38.
PMID: 19996475
PMC: 3398051.
Psychopharmacology of ADHD in pediatrics: current advances and issues.
Greydanus D, Nazeer A, Patel D
Neuropsychiatr Dis Treat. 2009; 5:171-81.
PMID: 19557112
PMC: 2695228.
DOI: 10.2147/ndt.s4075.
Personality traits among ADHD adults: implications of late-onset and subthreshold diagnoses.
Faraone S, Kunwar A, Adamson J, Biederman J
Psychol Med. 2008; 39(4):685-93.
PMID: 18588742
PMC: 2874959.
DOI: 10.1017/S0033291708003917.
Acute effects of methylphenidate on neuropsychological parameters in adults with ADHD: possible relevance for therapy.
Kurscheidt J, Peiler P, Behnken A, Abel S, Pedersen A, Suslow T
J Neural Transm (Vienna). 2008; 115(2):357-62.
PMID: 18264813
DOI: 10.1007/s00702-008-0871-4.
Combination pharmacotherapy for adult ADHD.
Adler L, Reingold L, Morrill M, Wilens T
Curr Psychiatry Rep. 2006; 8(5):409-15.
PMID: 16968624
DOI: 10.1007/s11920-006-0044-9.
Clinical pharmacokinetics of atomoxetine.
Sauer J, Ring B, Witcher J
Clin Pharmacokinet. 2005; 44(6):571-90.
PMID: 15910008
DOI: 10.2165/00003088-200544060-00002.
Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder.
Turner D, Blackwell A, Dowson J, McLean A, Sahakian B
Psychopharmacology (Berl). 2004; 178(2-3):286-95.
PMID: 15338103
DOI: 10.1007/s00213-004-1993-5.